Usefulness of Coronary Artery Calcium to Identify Adults of Sufficiently High Risk for Atherothrombotic Cardiovascular Events to Consider Low-Dose Rivaroxaban Thromboprophylaxis (From MESA)

Low-dose rivaroxaban was effective in secondary prevention of atherosclerotic cardiovascular disease (ASCVD) in the COMPASS trial. There is no established role, however, for oral anticoagulants in primary prevention. We evaluated whether coronary artery calcium (CAC) scoring identifies a high-risk p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Cardiol
Main Authors: Arps, Kelly, Rifai, Mahmoud Al, Blaha, Michael J., Michos, Erin D., Nasir, Khurram, Yeboah, Joseph, Budoff, Matthew J., Blumenthal, Roger S., Bittencourt, Marcio S., McEvoy, John W.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6755041/
https://ncbi.nlm.nih.gov/pubmed/31416591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2019.07.016
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados